CGON vs. RAPT

Last updated Jun 3, 2026

CGON (CG Oncology, Inc) and RAPT (RAPT Therapeutics, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. At a 0.32 correlation, their price movements are largely independent.

Performance

CGON vs. RAPT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in CG Oncology, Inc (CGON) and RAPT Therapeutics, Inc. (RAPT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

CGON

• 1D: -6.25%
• 1M: -16.21%
• YTD: 33.74%
• 6M: 34.23%
• 1Y: 108.84%
• 3Y*: —
• 5Y*: —
• 10Y*: —

RAPT

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CGON vs. RAPT - Yearly Performance Comparison

	2026 (YTD)	2025	2024
CGON CG Oncology, Inc	33.74%	44.77%	-22.84%
RAPT RAPT Therapeutics, Inc.	71.30%	167.96%	-93.40%

Correlation

The correlation between CGON and RAPT is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.20
Correlation (All Time) Calculated using the full available price history since Jan 26, 2024	0.32

The correlation between CGON and RAPT shifts across timeframes, from 0.20 (1 year) to 0.32 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap CGON : $4.69B RAPT : $1.56B
EPS CGON : -$1.61 RAPT : -$3.92
PB Ratio CGON : 4.30 RAPT : 10.29
Total Revenue (TTM) CGON : $5.07M RAPT : $0.00
Gross Profit (TTM) CGON : -$2.54M RAPT : -$200.00K
EBITDA (TTM) CGON : -$191.51M RAPT : -$108.01M

Return for Risk

CGON vs. RAPT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CGON

CGON Risk / Return Rank: 87
CGON Sharpe Ratio Rank: 86
CGON Sortino Ratio Rank: 87
CGON Omega Ratio Rank: 82
CGON Calmar Ratio Rank: 90
CGON Martin Ratio Rank: 93

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CGON vs. RAPT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for CG Oncology, Inc (CGON) and RAPT Therapeutics, Inc. (RAPT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CGON	RAPT	Difference
Sharpe ratio Return per unit of total volatility	1.93	—	—
Sortino ratio Return per unit of downside risk	2.92	—	—
Omega ratio Gain probability vs. loss probability	1.33	—	—
Calmar ratio Return relative to maximum drawdown	4.68	—	—
Martin ratio Return relative to average drawdown	15.68	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	CGON	RAPT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.93	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.29	—	—

Drawdowns

Drawdown Indicators

	CGON	RAPT	Difference
Max Drawdown Largest peak-to-trough decline	-67.47%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-24.96%	—	—
Current Drawdown Current decline from peak	-24.96%	—	—
Average Drawdown Average peak-to-trough decline	-25.93%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	7.45%	—	—

Volatility

Volatility by Period

	CGON	RAPT	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.68%	—	—
Volatility (6M) Calculated over the trailing 6-month period	41.79%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	56.79%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	64.24%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	64.24%	—	—

Dividends

CGON vs. RAPT - Dividend Comparison

Neither CGON nor RAPT has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both CGON and RAPT in my portfolio?

CGON and RAPT have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.